Noteworthy

Sep 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Bill Trombetta surveys the landscape of pharma financials over the past year, and shows which companies rode the wave to the top of the industry in delivering value to shareholders.
Aug 01, 2011
Pharmaceutical Executive
Is Google+ the social media platform that pharma has been waiting for?
Aug 01, 2011
Pharmaceutical Executive
A Q&A with Andrew Webber, President and CEO of the National Business Coalition on Health
Aug 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
When faced with legislative scrutiny, be prepared, be truthful, and don't be afraid to say 'I don't know'...
Aug 01, 2011
Pharmaceutical Executive
A Q&A with Kristin Peck, the drugmaker's Executive Vice President, Worldwide Business Development and Innovation.
Aug 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
When it comes to the emerging markets, executing a few key elements of success are more important than ever.
Jul 25, 2011
By Pharmaceutical Executive Editors
After years of falling sales, the industry finally has a new tool. But can the iPad really transform these trends or is it just a tech fad? Boyan Zuzek, CIO at EKR Therapeutics, offers his views in this Pharma Faceoff episode.
Jul 13, 2011
By Pharmaceutical Executive Editors
Do drug co-pay cards lead to skyrocketing healthcare inflation or provide patients access to valuable medicines?
Jul 01, 2011
Pharmaceutical Executive
Taking Onyx Pharmaceuticals to new heights—CEO Tony Coles talks to PharmExec about the midsize company's transition from adolescence to adulthood.
Jul 01, 2011
Pharmaceutical Executive
'Like' and 'Dislike' practices in the virtual Facebook pharmaceutical world.
native1_300x100
lorem ipsum